Page last updated: 2024-10-23

azathioprine and Innate Inflammatory Response

azathioprine has been researched along with Innate Inflammatory Response in 105 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research Excerpts

ExcerptRelevanceReference
" Methotrexate is probably slightly more efficacious than mycophenolate in achieving control of inflammation, including steroid-sparing control (moderate-certainty evidence), although there was insufficient evidence to prefer one medication over the other in the VKH subgroup (very low-certainty evidence)."5.22Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults. ( Edwards Mayhew, RG; Leslie, L; Li, T; McCann, P; Palestine, AG; Strong Caldwell, A, 2022)
"Our work supports the strong evidence that individuals with TPMT variant homozygosity are at high risk of severe neutropenia, whereas TPMT heterozygotes are not at increased risk of ADRs at standard doses of azathioprine."5.15A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study. ( Alder, JE; Andrews, J; Bruce, I; Elles, R; Elliott, RA; Fargher, E; Griffiths, CE; Heise, M; Houston, JB; Newman, WG; Ollier, WE; Payne, D; Payne, K; Pushpakom, S; Qasim, F; Ramsden, SC; Ray, DW; Roberts, SA; Shaffer, J; Sidgwick, GP; Tricker, K, 2011)
"In this paper, we describe a case of an acute cytomegalovirus (CMV) infection in a 35-year-old male patient with Crohn's disease being in remission while receiving azathioprine therapy."3.88Severe complication during remission of Crohn's disease: hemophagocytic lymphohistiocytosis due to acute cytomegalovirus infection. ( Aichinger, W; Kirchgatterer, A; Miechowiecki, J; Prammer, W; Stainer, W; Tuppy, H; Wallner, G, 2018)
" Combined immunosuppressive therapy with prednisone and cyclophosphamide might be needed to treat recurrent thrombosis due to Behçet disease."3.80Recurrent right atrial thrombosis due to Behçet disease. ( Fukuda, K; Kuno, T; Kuwana, M; Murata, M; Ono, T; Satoh, T; Tamura, Y, 2014)
"Azathioprine was moderately effective as a single corticosteroid-sparing immunosuppressive agent in terms of control of inflammation and corticosteroid-sparing benefits, but required several months to achieve treatment goals; it seems especially useful for patients with intermediate uveitis."3.75Azathioprine for ocular inflammatory diseases. ( Foster, CS; Jabs, DA; Kempen, JH; Levy-Clarke, GA; Liesegang, TL; Newcomb, CW; Nussenblatt, RB; Pasadhika, S; Pujari, SS; Rosenbaum, JT; Suhler, EB; Thorne, JE, 2009)
"Extrapolation from transplant, rheumatology, skin disease, and inflammatory bowel disease cohorts to the ocular inflammation setting suggest that: 1) alkylating agents increase hematologic malignancy risk and cyclophosphamide increases bladder cancer risk, but less so with < or =18 months' duration of therapy and hydration, respectively; 2) calcineurin inhibitors and azathioprine probably do not increase total cancer risk to a detectable degree, except perhaps some other risk factors (uncommon in ocular inflammation patients) might interact with the former to raise risk; 3) tumor necrosis factor (TNF) inhibitors may accelerate diagnosis of cancer in the first six to 12 months, but probably do not increase long-term cancer risk; and 4) changes in risk with methotrexate, mycophenolate mofetil, and daclizumab appear negligible, although nontransplant data are limited for the latter agents."3.74Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. ( Daniel, E; Foster, CS; Gangaputra, S; Helzlsouer, KJ; Jabs, DA; Kempen, JH; Levy-Clarke, GA; Nussenblatt, RB; Rosenbaum, JT; Suhler, EB; Thorne, JE, 2008)
"These data suggest that the time to control of ocular inflammation is faster with mycophenolate than with methotrexate."3.74Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. ( Dunn, JP; Galor, A; Jabs, DA; Kedhar, SR; Leder, HA; Peters, GB; Thorne, JE, 2008)
"In the absence of calcium channel blockers, this study showed that pharmacologic variables, such as cyclosporin serum concentration, prednisolone and azathioprine dosages, and time since transplant, are strongly related to gingival overgrowth."3.74Demographic, pharmacologic, and periodontal variables for gingival overgrowth in subjects medicated with cyclosporin in the absence of calcium channel blockers. ( Costa, JE; Cota, LO; Ferreira, SD; Lages, EJ; Oliveira Costa, F; Oliveira, AM, 2007)
"Graves orbitopathy is both disabling and disfiguring."3.30Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED Trial. ( Cook, A; Dayan, CM; French, R; Gattamaneni, R; Hanna, S; Hills, R; Jackson, S; Lee, RWJ; Li, C; Pell, J; Plowman, N; Rajendram, R; Taylor, P; Uddin, JM; Wilson, V, 2023)
"Immunosuppression in aqueous-deficient dry eye disease (ADDE) is required not only to improve the symptoms and signs but also to prevent further progression of the disease and its sight-threatening sequelae."3.01Role of topical and systemic immunosuppression in aqueous-deficient dry eye disease. ( Amescua, G; Basu, S; Donthineni, PR; Kate, A; Quinones, VLP; Shanbhag, SS, 2023)
"UC related colorectal cancer develop in an unpredictable manner with respect to disease duration and site questioning the validity of strict screening protocol."2.53Inflammatory bowel disease in India - Past, present and future. ( Ray, G, 2016)
" New diagnostic and therapeutic algorithms are needed to directly determine the functional importance of the influence of host genetic factors on choice and dosage scheduling of therapy."2.42Pharmacogenetics of inflammatory bowel disease. ( Farrell, R; Kelleher, D; McManus, R, 2004)
" However, treatment is limited by adverse events-in particular, myelotoxicity."1.72TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real-World Clinical Results. ( Anandi, P; Birdwell, KA; Chung, CP; Cox, NJ; Dale Plummer, W; Daniel, LL; Dickson, AL; Dupont, WD; Feng, Q; Hung, AM; Kawai, V; Liu, G; Reese, T; Stein, CM; Wei, WQ; Zanussi, J, 2022)
"For patients with moderate to severe ulcerative colitis, the first line for induction therapy options includes biologic agents (with or without an immunomodulator) or glucocorticoids."1.72Use of Novel Biological Agent in Severe Ulcerative Colitis with Poor Response to Initial Therapy: A Case Report. ( Basnet, BK; Bhandari, A, 2022)
"IR-CAP could well be 'axonal CIDP' in view of clinical similarity, but not proven as yet."1.56Chronic inflammatory axonal polyneuropathy. ( Alsharabati, M; King, P; Lu, L; Morgan, MB; Oh, SJ, 2020)
"Azathioprine was the treatment prescribed in the four patients with NMOSD."1.51Inflammatory demyelinating diseases of the central nervous system in Niger. ( Adehossi Omar, É; Assadeck, H; Douma Maiga, D; Hassane Djibo, F; Mamadou, Z; Toudou Daouda, M, 2019)
"Oral steroids are recommended for the treatment of nasal polyps (NPs), but prolonged use is avoided because of side effects."1.51Effects of azathioprine and its metabolites on inflammatory cytokines in human nasal polyp organ cultures. ( Eom, DW; Lee, JH; Oh, MY; Park, WJ; Yeo, NK, 2019)
"28 patients treated for Ormond's disease were included."1.43Combination of Steroids and Azathioprine in the Treatment of Ormond's Disease--A Single Centre Retrospective Analysis. ( Kolombo, I; Průcha, M; Štádler, P, 2016)
"Giant cell hepatitis with autoimmune hemolytic anemia (GCH-AHA) is presumed to be an autoimmune disease, but the mechanism of liver injury is unknown."1.40Humoral immune mechanism of liver injury in giant cell hepatitis with autoimmune hemolytic anemia. ( Alvarez, F; Bass, LM; Melin-Aldana, H; Romero, R; Roy, CC; Vos, MB; Whitington, PF, 2014)
"Ocular motility was reduced."1.39Cogan's syndrome associated with orbital inflammation. ( Knapp, C; Mukherjee, R; Shahid, FL, 2013)
"Crohn's disease is a chronic, inflammatory disease of the gastrointestinal tract, affecting both children and adults."1.39Extracorporeal photopheresis for the treatment of severe, refractory steroid dependent pediatric Crohn's Disease. ( Bertolone, S; Cheerva, A; Dillard, R, 2013)
"Forty-nine patients affected by systemic sclerosis (44 women and five men, mean age 52."1.35Cyclophosphamide treatment improves microvessel damage in systemic sclerosis. ( Bambara, LM; Biasi, D; Caramaschi, P; Mahamid, H; Pieropan, S; Tinazzi, I; Volpe, A, 2009)
"Polyarteritis nodosa is a necrotizing vasculitis affecting medium and small-sized arteries throughout the body, including ocular tissues."1.29Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy. ( Akova, YA; Foster, CS; Jabbur, NS, 1993)
" The kinetics of the monocyte also changes under the low dosage of azathioprine."1.25The effect of azathioprine (Imuran) on the cell cycle of promonocytes and the production of monocytes in the bone marrow. ( Diesselhoff-Den Dulk, MM; Gassmann, AE; van Furth, R, 1975)
" Two dosage levels were used: a high dose of 200mg/kg which is the maximum tolerated daily dose in mice, and low dose of 3 mg/kg which is about equivalent to a nontoxic, immunosuppressive, anti-inflammatory dose in man."1.25The effect of azathioprine (Imuran) on the kinetics of monocytes and macrophages during the normal steady state and an acute inflammatory reaction. ( Gassmann, AE; van Furth, R, 1975)
"A case of juvenile rheumatoid arthritis with vasculitis is presented."1.25Digital artery thrombosis and vasculitis in juvenile rheumatoid arthritis. ( Carson, RA, 1973)

Research

Studies (105)

TimeframeStudies, this research(%)All Research%
pre-199038 (36.19)18.7374
1990's7 (6.67)18.2507
2000's21 (20.00)29.6817
2010's30 (28.57)24.3611
2020's9 (8.57)2.80

Authors

AuthorsStudies
Saunders, MJ1
Edwards, BS1
Zhu, J1
Sklar, LA1
Graves, SW1
Dickson, AL1
Daniel, LL1
Zanussi, J1
Dale Plummer, W1
Wei, WQ1
Liu, G1
Reese, T1
Anandi, P1
Birdwell, KA1
Kawai, V1
Cox, NJ1
Dupont, WD1
Hung, AM1
Feng, Q1
Stein, CM1
Chung, CP1
Edwards Mayhew, RG1
Li, T1
McCann, P1
Leslie, L1
Strong Caldwell, A1
Palestine, AG1
Bhandari, A1
Basnet, BK1
Taylor, P1
Rajendram, R1
Hanna, S1
Wilson, V1
Pell, J1
Li, C1
Cook, A1
Gattamaneni, R1
Plowman, N1
Jackson, S1
Hills, R1
French, R1
Uddin, JM1
Lee, RWJ1
Dayan, CM1
Kate, A1
Shanbhag, SS1
Donthineni, PR1
Amescua, G1
Quinones, VLP1
Basu, S1
López Riquelme, I1
Fernández Ballesteros, MD1
Perea Polak, A1
Serrano Ordoñez, A1
Martínez Pilar, L1
Kutluturk, I1
Agarwal, A1
Shulman, S1
Vitale, A1
Parodi, MB1
Conrady, CD1
Hurtikova, K1
Cunha Souza, E1
Rodriguez, EC1
Chhablani, J1
Tappeiner, C1
Gerding, H1
Zinkernagel, MS1
Tucker, W1
Munk, MR1
Oh, SJ1
Lu, L1
Alsharabati, M1
Morgan, MB1
King, P1
Lin, G1
Li, M1
Xu, N1
Wu, X1
Liu, J1
Wu, Y1
Zhang, Q1
Cai, J1
Gao, C1
Su, Z1
Bellon, H1
Vandermeulen, E1
Verleden, SE1
Heigl, T1
Vriens, H1
Lammertyn, E1
Verlinden, L1
Vanhove, T1
Verstuyf, M1
Hoet, P1
Vos, R1
Verleden, GM1
Vanaudenaerde, BM1
Citterio-Quentin, A1
Moulsma, M1
Gustin, MP1
Lachaux, A1
Boulieu, R1
Primas, C1
Reinisch, S1
Novacek, G1
Miechowiecki, J1
Stainer, W1
Wallner, G1
Tuppy, H1
Aichinger, W1
Prammer, W1
Kirchgatterer, A1
Zhou, Z1
Jing, Y1
Ran, Y1
Zhao, J1
Zhou, L2
Wang, BM1
Assadeck, H1
Toudou Daouda, M1
Adehossi Omar, É1
Mamadou, Z1
Hassane Djibo, F1
Douma Maiga, D1
Ginestal, R1
Pérez-Köhler, B1
Pérez-López, P1
Rodríguez, M1
Pascual, G1
Cebrián, D1
Bellón, JM1
García-Moreno, F1
Ziade, F1
Rungoe, C1
Kallemose, T1
Paerregaard, A1
Wewer, AV1
Jakobsen, C1
Yeo, NK1
Park, WJ1
Eom, DW1
Oh, MY1
Lee, JH1
Khare, V1
Krnjic, A1
Frick, A1
Gmainer, C1
Asboth, M1
Jimenez, K1
Lang, M1
Baumgartner, M1
Evstatiev, R1
Gasche, C1
Lima, BR1
Nussenblatt, RB3
Sen, HN1
Shahid, FL1
Mukherjee, R1
Knapp, C1
Cheerva, A1
Dillard, R1
Bertolone, S1
Whitington, PF1
Vos, MB1
Bass, LM1
Melin-Aldana, H1
Romero, R1
Roy, CC1
Alvarez, F1
Matsuo, K1
Sasaki, E1
Higuchi, S1
Takai, S1
Tsuneyama, K1
Fukami, T1
Nakajima, M1
Yokoi, T1
Yarur, AJ1
Abreu, MT1
Deshpande, AR1
Kerman, DH1
Sussman, DA1
Kuno, T1
Tamura, Y1
Ono, T1
Murata, M1
Kuwana, M1
Satoh, T1
Fukuda, K1
Zhang, S1
Ye, H1
Zhang, Z1
Lu, B1
Yang, Y1
He, M1
Wu, H1
Wang, Y1
Pan, L1
Li, Y1
Hu, R1
Dhaliwal, HK1
Hoeroldt, BS1
Dube, AK1
McFarlane, E1
Underwood, JC1
Karajeh, MA1
Gleeson, D1
dos Santos, LC1
Costa, AV1
Lopes, LG1
Leonel, AJ1
Aguilar, EC1
Noviello, Mde L1
Ferrari, Mde L1
Alvarez-Leite, JI1
Greco, A1
Marinelli, C1
Fusconi, M1
Macri, GF1
Gallo, A1
De Virgilio, A1
Zambetti, G1
de Vincentiis, M1
Průcha, M1
Kolombo, I1
Štádler, P1
Ray, G1
Kempen, JH2
Gangaputra, S1
Daniel, E1
Levy-Clarke, GA2
Rosenbaum, JT2
Suhler, EB2
Thorne, JE3
Foster, CS3
Jabs, DA3
Helzlsouer, KJ1
Galor, A1
Leder, HA1
Kedhar, SR1
Dunn, JP1
Peters, GB1
Caramaschi, P1
Volpe, A1
Pieropan, S1
Tinazzi, I1
Mahamid, H1
Bambara, LM1
Biasi, D1
Pasadhika, S1
Newcomb, CW1
Liesegang, TL1
Pujari, SS1
Speich, R1
Schneider, S1
Hofer, M1
Irani, S1
Vogt, P1
Weder, W1
Boehler, A1
Lu, Z1
Yang, G1
Ba, J1
Dou, J1
Mu, Y1
Lu, J1
Gabilondo, I1
Saiz, A1
Graus, F1
Villoslada, P1
Newman, WG1
Payne, K1
Tricker, K1
Roberts, SA1
Fargher, E1
Pushpakom, S1
Alder, JE1
Sidgwick, GP1
Payne, D1
Elliott, RA1
Heise, M1
Elles, R1
Ramsden, SC1
Andrews, J1
Houston, JB1
Qasim, F1
Shaffer, J1
Griffiths, CE1
Ray, DW1
Bruce, I1
Ollier, WE1
Bosco, JJ1
Suan, D1
Varikatt, W1
Lin, MW1
Sharir, M1
Isakov, I1
De León, EJ1
Olmedo, DA1
Solís, PN1
Gupta, MP1
Terencio, MC1
Marshall, E1
Lecube, A1
Francisco, G1
Rodríguez, D1
Ortega, A1
Codina, A1
Hernández, C1
Simó, R1
Pethig, K1
Heublein, B1
Wahlers, T1
Dannenberg, O1
Oppelt, P1
Haverich, A1
Barnes, BH1
Borowitz, SM1
Saulsbury, FT1
Hellems, M1
Sutphen, JL1
Thomas, CW1
Myhre, GM1
Tschumper, R1
Sreekumar, R1
Jelinek, D1
McKean, DJ1
Lipsky, JJ1
Sandborn, WJ1
Egan, LJ1
Jeffery, DR1
Kelleher, D1
Farrell, R1
McManus, R1
El Mezni, F1
Saiji, E1
Ayadi-Kaddour, A1
Ismail, O1
Braham, E1
Ben Turkia, H1
Hamzaoui, A1
Golding, RM1
Giles, LG1
Schedel, J1
Gödde, A1
Schütz, E1
Bongartz, TA1
Lang, B1
Schölmerich, J1
Müller-Ladner, U1
Cavaletti, G1
Tweezer-Zaks, N1
Ben-Horin, S1
Schiby, G1
Bank, I1
Levi, Y1
Livneh, A1
Langevitz, P1
Oliveira Costa, F1
Ferreira, SD1
Lages, EJ1
Costa, JE1
Oliveira, AM1
Cota, LO1
Gisbert, JP1
Luna, M1
González-Lama, Y1
Pousa, ID1
Velasco, M1
Moreno-Otero, R1
Maté, J1
Stutzman, WJ1
Marmor, L1
Miner, R1
Foster, J1
Wechter, WJ1
Loughman, BE1
van Furth, R6
Häyry, P3
Ahonen, J4
von Willebrand, E3
Eklund, B3
Höckekstedt, K1
Kauste, A1
Taskinen, E2
Lautenschlager, I2
Lalla, M1
Sarelin, H1
Krowka, MJ1
Breuer, RI1
Kehoe, TJ1
Mason, JW1
Billingham, ME1
Ricci, DR1
Tytgat, GN1
Roozendaal, K1
Winter, W1
Esseveld, MR1
Kirkin, BV1
Mikhaĭlova, TL1
Maiat, KE1
Soin, AS1
Rasmussen, A1
Jamieson, NV1
Watson, CJ1
Friend, PJ1
Wight, DG1
Calne, RY1
Akova, YA1
Jabbur, NS1
Górski, A1
Mrowiec, T1
Paczek, L1
Stepień-Sopniewska, B1
Martínez-Rueda, JO1
Arce-Salinas, CA1
Kraus, A1
Alcocer-Varela, J1
Alarcón-Segovia, D1
Soots, A1
Krogerus, L1
Saarinen, O1
Salminen, US1
Uusitalo, M1
Ikonen, T1
Morris, RE1
Harjula, AL1
Weiner, GM1
Jenicke, L1
Buchert, R1
Bohuslavizki, KH1
Winkelstein, A1
Faust, G1
Zöller, B1
Brinkrolf, H1
Clarke, AK1
Vernon-Roberts, B1
Currey, HL2
Thompson, J1
Gassmann, AE3
Diesselhoff-Den Dulk, MM1
Katz, SM1
Greenstein, SM1
Simonian, S1
Miller, A1
Hakki, A1
Sowinski, J1
Biesecker, G1
Mellert, J1
Hopt, UT1
Erath, F1
Hölzer, H1
Guettier, C1
Nochy, D1
Hinglais, N1
Pelletier, L1
Mandet, C1
Bedrossian, J1
Duboust, A1
Moulonguet Doleris, L1
Camilleri, JP1
Bariety, J1
Salmela, K2
Höckerstedt, K2
Pettersson, E2
Koskimies, S2
Calthorpe, CM1
Watson, PG1
McCartney, AC1
Miller, B1
Martini, GA1
Levy, L1
Wagner, H1
Junge-Hülsing, G2
Müller, US2
Hrubesch, M1
Büchner, T1
Wirth, W2
Hauss, WH2
Thöne, F1
Claman, HN1
Karr, RM1
Kohler, PF1
Mass, MF1
McIntosh, RM1
Sams, WM1
Small, P1
Stanford, RE1
Thorne, EG1
Jayson, MI1
Jones, DE1
Beck, FJ1
Whitehouse, MW1
Dukes, M1
Chan, WC1
Willoughby, DA1
Carson, RA1
Harket, R1
Fausa, O1
Nygaard, K1
MacSween, RN1
Gondos, B1
White, P1
Benfield, JR1
Arrigoni-Martelli, E1
Schiatti, P1
Selva, D1
Fricke, R1
Rohne, HP1
Schmidt, JG1
Lischka, G1
Booth, RA1
Ansari, MT1
Loit, E1
Tricco, AC1
Weeks, L1
Doucette, S1
Skidmore, B1
Sears, M1
Sy, R1
Karsh, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial[NCT01829295]Phase 3216 participants (Actual)Interventional2013-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Participants Achieving Treatment Success After Switching to Other Medication (Phase II, 0-6 Months)

Controlled ocular inflammation (≤ 0.5+ anterior chamber cells, ≤ 0.5+ vitreous haze, no active retinal/choroidal lesions in both eyes) with 7.5 mg/day of oral prednisone and ≤ 2 drops/day of topical 1% prednisolone acetate for patients who crossed over to other medication following treatment failure at 6 months (or earlier). (NCT01829295)
Timeframe: 6 Months

InterventionParticipants (Count of Participants)
Switched Over to Methotrexate20
Switched Over to Mycophenolate Mofetil7

Number of Participants Achieving Treatment Success at 12 Months on Same Medication (Phase I, 6-12 Months)

Controlled ocular inflammation (≤ 0.5+ anterior chamber cells, ≤ 0.5+ vitreous haze, no active retinal/choroidal lesions in both eyes) with 7.5 mg/day of oral prednisone and ≤ 2 drops/day of topical 1% prednisolone acetate in patients who were a treatment success at the primary outcome of 6 months. (NCT01829295)
Timeframe: 12 Months

InterventionParticipants (Count of Participants)
Methotrexate48
Mycophenolate Mofetil40

Number of Participants Achieving Treatment Success at 6 Months (Phase I, 0-6 Months)

Controlled ocular inflammation (≤ 0.5+ anterior chamber cells, ≤ 0.5+ vitreous haze, no active retinal/choroidal lesions in both eyes) with 7.5 mg/day of oral prednisone and ≤ 2 drops/day of topical 1% prednisolone acetate. (NCT01829295)
Timeframe: 6 Months

InterventionParticipants (Count of Participants)
Methotrexate64
Mycophenolate Mofetil56

Reviews

16 reviews available for azathioprine and Innate Inflammatory Response

ArticleYear
Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults.
    The Cochrane database of systematic reviews, 2022, 10-31, Volume: 10

    Topics: Adult; Antirheumatic Agents; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammat

2022
Role of topical and systemic immunosuppression in aqueous-deficient dry eye disease.
    Indian journal of ophthalmology, 2023, Volume: 71, Issue:4

    Topics: Azathioprine; Dry Eye Syndromes; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Inflam

2023
Pharmacogenetics of drugs used in the treatment of ocular inflammatory diseases.
    Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:7

    Topics: Adrenal Cortex Hormones; Alkylating Agents; Anti-Inflammatory Agents; Antimetabolites; Azathioprine;

2013
Therapeutic drug monitoring in patients with inflammatory bowel disease.
    World journal of gastroenterology, 2014, Apr-07, Volume: 20, Issue:13

    Topics: Adalimumab; Antibodies; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Dru

2014
Clinic manifestations in granulomatosis with polyangiitis.
    International journal of immunopathology and pharmacology, 2016, Volume: 29, Issue:2

    Topics: Azathioprine; Cyclophosphamide; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Incidence

2016
Inflammatory bowel disease in India - Past, present and future.
    World journal of gastroenterology, 2016, Sep-28, Volume: 22, Issue:36

    Topics: Aminosalicylic Acid; Antitubercular Agents; Asia, Southeastern; Azathioprine; Biological Products; B

2016
Behçet's disease--current status.
    The Israel Medical Association journal : IMAJ, 2002, Volume: 4, Issue:11 Suppl

    Topics: Angiogenesis Inhibitors; Azathioprine; Behcet Syndrome; C-Reactive Protein; Drug Therapy, Combinatio

2002
Use of combination therapy with immunomodulators and immunosuppressants in treating multiple sclerosis.
    Neurology, 2004, Dec-28, Volume: 63, Issue:12 Suppl 6

    Topics: Azathioprine; Drug Antagonism; Drug Resistance; Drug Therapy, Combination; Humans; Immunologic Facto

2004
Pharmacogenetics of inflammatory bowel disease.
    Novartis Foundation symposium, 2004, Volume: 263

    Topics: Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azathioprine; Gastr

2004
Current status and future prospective of immunointervention in multiple sclerosis.
    Current medicinal chemistry, 2006, Volume: 13, Issue:19

    Topics: Azathioprine; Bone Marrow Transplantation; Cyclophosphamide; Humans; Immunoglobulins, Intravenous; I

2006
Immunology in drug research.
    Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques, 1984, Volume: 28

    Topics: Animals; Anti-Inflammatory Agents; Antibody Formation; Azathioprine; Cyclophosphamide; Cyclosporins;

1984
The effects of azathioprine and 6 MP on immunity.
    Journal of immunopharmacology, 1979, Volume: 1, Issue:4

    Topics: Animals; Azathioprine; Humans; Immunity; Immunosuppressive Agents; Inflammation; Lymphocytes; Mercap

1979
[Immunovasculitis-- differential diagnosis and therapy of inflammatory systemic diseases].
    Die Medizinische Welt, 1976, Jun-25, Volume: 27, Issue:26

    Topics: Adult; Angiography; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Diagnosis, Differentia

1976
Macrophage activity and clinical immunology. Origin and kinetics of mononuclear phagocytes.
    Annals of the New York Academy of Sciences, 1976, Volume: 278

    Topics: Animals; Azathioprine; Glucocorticoids; Granuloma; Humans; Hydrocortisone; Inflammation; Kinetics; M

1976
[What is secured in the therapy of chronic inflammatory colonic diseases?].
    Der Internist, 1974, Volume: 15, Issue:12

    Topics: Administration, Topical; Amebiasis; Azathioprine; Chronic Disease; Colitis; Colitis, Ulcerative; Col

1974
Assessment of thiopurine S-methyltransferase activity in patients prescribed thiopurines: a systematic review.
    Annals of internal medicine, 2011, Jun-21, Volume: 154, Issue:12

    Topics: Chronic Disease; Genetic Testing; Genotype; Humans; Inflammation; Mercaptopurine; Methyltransferases

2011

Trials

8 trials available for azathioprine and Innate Inflammatory Response

ArticleYear
Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED Trial.
    The Journal of clinical endocrinology and metabolism, 2023, 09-18, Volume: 108, Issue:10

    Topics: Azathioprine; Follow-Up Studies; Graves Ophthalmopathy; Humans; Inflammation; Quality of Life; Treat

2023
A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study.
    Pharmacogenomics, 2011, Volume: 12, Issue:6

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Drug-Related Side Effects and Adverse

2011
Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2004, Volume: 23, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; C-Reactive Protein; Cyclosporine; Female; Hea

2004
Impact of thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations in patients with chronic inflammatory diseases.
    Annals of the New York Academy of Sciences, 2006, Volume: 1069

    Topics: Adult; Aged; Azathioprine; Chronic Disease; Cohort Studies; Female; Guanine Nucleotides; Humans; Inf

2006
Effect of cyclosporin A on the situ inflammatory response of human renal allograft rejection. A preliminary report.
    Scandinavian journal of immunology, 1982, Volume: 16, Issue:2

    Topics: Animals; Azathioprine; Clinical Trials as Topic; Creatinine; Cyclosporins; Eosinophilia; Follow-Up S

1982
[Diagnosis and treatment of inflammatory infiltrates of the abdominal cavity in Crohn disease].
    Khirurgiia, 1994, Issue:10

    Topics: Abdomen; Anti-Inflammatory Agents; Azathioprine; Combined Modality Therapy; Crohn Disease; Drug Ther

1994
Effects of azathioprine, cyclosporine, and steroids on the graft and on cytologic patterns of rejection.
    Transplantation proceedings, 1987, Volume: 19, Issue:1 Pt 2

    Topics: Azathioprine; Biopsy, Needle; Clinical Trials as Topic; Cyclosporins; Drug Therapy, Combination; Gra

1987
Effects of cyclosporine, azathioprine, and steroids on the renal transplant, on the cytologic patterns of intragraft inflammation, and on concomitant rejection-associated changes in recipient blood.
    Transplantation proceedings, 1988, Volume: 20, Issue:2 Suppl 2

    Topics: Adult; Azathioprine; Cyclosporins; Graft Rejection; Humans; Inflammation; Kidney Diseases; Kidney Tr

1988

Other Studies

81 other studies available for azathioprine and Innate Inflammatory Response

ArticleYear
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
    Current protocols in cytometry, 2010, Volume: Chapter 13

    Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr

2010
TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real-World Clinical Results.
    Clinical pharmacology and therapeutics, 2022, Volume: 111, Issue:1

    Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Bone Marrow Diseases; Cohort Studies; Female; Humans;

2022
Use of Novel Biological Agent in Severe Ulcerative Colitis with Poor Response to Initial Therapy: A Case Report.
    JNMA; journal of the Nepal Medical Association, 2022, Sep-01, Volume: 60, Issue:253

    Topics: Adalimumab; Azathioprine; Biological Factors; Colitis, Ulcerative; Humans; Inflammation; Mesalamine

2022
Azathioprine in hidradenitis suppurativa with inflammatory phenotype: a case series of 11 patients.
    International journal of dermatology, 2023, Volume: 62, Issue:10

    Topics: Azathioprine; Hidradenitis Suppurativa; Humans; Inflammation; Quality of Life; Retrospective Studies

2023
The Clinical Characteristics of Unilateral Placoid Pigment Epitheliopathies.
    Ocular immunology and inflammation, 2021, Aug-18, Volume: 29, Issue:6

    Topics: Adolescent; Adult; Azathioprine; Choroid; Choroiditis; Drug Therapy, Combination; Female; Follow-Up

2021
Chronic inflammatory axonal polyneuropathy.
    Journal of neurology, neurosurgery, and psychiatry, 2020, Volume: 91, Issue:11

    Topics: Adolescent; Adult; Aged; Autoimmune Diseases of the Nervous System; Axons; Azathioprine; Biopsy; Chi

2020
Anti-Inflammatory Effects of
    BioMed research international, 2020, Volume: 2020

    Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Azathioprine; Chromatography, Liquid; Colitis; Colitis

2020
The Effect of Immunosuppression on Airway Integrity.
    Transplantation, 2017, Volume: 101, Issue:12

    Topics: Azathioprine; Bronchiolitis Obliterans; Cyclosporine; Dexamethasone; Endothelial Cells; Epithelial C

2017
ITPA Activity in Children Treated by Azathioprine: Relationship to the Occurrence of Adverse Drug Reactions and Inflammatory Response.
    Basic & clinical pharmacology & toxicology, 2018, Volume: 122, Issue:6

    Topics: Adolescent; Azathioprine; Biomarkers; Child; Child, Preschool; Female; Humans; Immunosuppressive Age

2018
Letter: addition of azathioprine to infliximab maintenance therapy in patients with anti-drug antibodies and subclinical inflammation.
    Alimentary pharmacology & therapeutics, 2018, Volume: 47, Issue:4

    Topics: Adalimumab; Antibody Formation; Azathioprine; Crohn Disease; Humans; Immunologic Factors; Immunosupp

2018
Severe complication during remission of Crohn's disease: hemophagocytic lymphohistiocytosis due to acute cytomegalovirus infection.
    Zeitschrift fur Gastroenterologie, 2018, Volume: 56, Issue:3

    Topics: Adult; Antiviral Agents; Azathioprine; Crohn Disease; Cytomegalovirus; Cytomegalovirus Infections; H

2018
[Role of Rac1 signaling pathway of azathioprine and peptidoglycan in the regulation of monocyte-macrophage apoptosis in Crohn's disease].
    Zhonghua nei ke za zhi, 2018, Apr-01, Volume: 57, Issue:4

    Topics: Apoptosis; Azathioprine; Case-Control Studies; Crohn Disease; Humans; Inflammation; Intestinal Mucos

2018
Inflammatory demyelinating diseases of the central nervous system in Niger.
    Revue neurologique, 2019, Volume: 175, Issue:4

    Topics: Adult; Aged; Azathioprine; Central Nervous System Diseases; Demyelinating Diseases; Disability Evalu

2019
Comparing the influence of two immunosuppressants (fingolimod, azathioprine) on wound healing in a rat model of primary and secondary intention wound closure.
    Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 2019, Volume: 27, Issue:1

    Topics: Animals; Azathioprine; Fingolimod Hydrochloride; Immunosuppressive Agents; Inflammation; Male; Model

2019
Biochemical Markers, Genotype, and Inflammation in Pediatric Inflammatory Bowel Disease: A Danish Population-Based Study.
    Digestive diseases (Basel, Switzerland), 2019, Volume: 37, Issue:2

    Topics: Adolescent; Azathioprine; Biomarkers; Child; Child, Preschool; Cohort Studies; Colitis, Ulcerative;

2019
Effects of azathioprine and its metabolites on inflammatory cytokines in human nasal polyp organ cultures.
    International forum of allergy & rhinology, 2019, Volume: 9, Issue:6

    Topics: Adolescent; Adult; Azathioprine; Cytokines; Female; Humans; Immunosuppressive Agents; Inflammation;

2019
Mesalamine and azathioprine modulate junctional complexes and restore epithelial barrier function in intestinal inflammation.
    Scientific reports, 2019, 02-26, Volume: 9, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis; Epithelial Cells; Inflammat

2019
Cogan's syndrome associated with orbital inflammation.
    Orbit (Amsterdam, Netherlands), 2013, Volume: 32, Issue:3

    Topics: Aged; Azathioprine; Cogan Syndrome; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressi

2013
Extracorporeal photopheresis for the treatment of severe, refractory steroid dependent pediatric Crohn's Disease.
    Journal of clinical apheresis, 2013, Volume: 28, Issue:5

    Topics: Antibodies, Monoclonal; Azathioprine; Child; Colostomy; Crohn Disease; Endoscopy; Gastrointestinal A

2013
Humoral immune mechanism of liver injury in giant cell hepatitis with autoimmune hemolytic anemia.
    Journal of pediatric gastroenterology and nutrition, 2014, Volume: 58, Issue:1

    Topics: Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Aut

2014
Involvement of oxidative stress and immune- and inflammation-related factors in azathioprine-induced liver injury.
    Toxicology letters, 2014, Jan-13, Volume: 224, Issue:2

    Topics: Animals; Azathioprine; Carrier Proteins; Chemical and Drug Induced Liver Injury; Female; Glutathione

2014
Recurrent right atrial thrombosis due to Behçet disease.
    The Canadian journal of cardiology, 2014, Volume: 30, Issue:10

    Topics: Anticoagulants; Azathioprine; Behcet Syndrome; Disease Progression; Heart Atria; Heart Diseases; Hum

2014
Successful diagnosis of hypothalamitis using stereotactic biopsy and treatment: a case report.
    Medicine, 2015, Volume: 94, Issue:5

    Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Biopsy, Needle; Diagnosis, Differential; Humans; Hypo

2015
Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis.
    The American journal of gastroenterology, 2015, Volume: 110, Issue:7

    Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Biomarkers; Biopsy; Drug Administration Schedul

2015
Combination of Azathioprine and Aminosalicylate Treatment Prevent Risk of Cardiovascular Disease in Women with Ulcerative Colitis by Reducing Inflammation.
    Medical science monitor : international medical journal of experimental and clinical research, 2015, Aug-07, Volume: 21

    Topics: Adult; Aminosalicylic Acid; Azathioprine; Biomarkers; Cardiovascular Diseases; Case-Control Studies;

2015
Combination of Steroids and Azathioprine in the Treatment of Ormond's Disease--A Single Centre Retrospective Analysis.
    Prague medical report, 2016, Volume: 117, Issue:1

    Topics: Azathioprine; Czech Republic; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive

2016
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence.
    American journal of ophthalmology, 2008, Volume: 146, Issue:6

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites; Azathioprine; Daclizumab

2008
Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.
    Ophthalmology, 2008, Volume: 115, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites; Azathioprine; Child; Female; Glucocorti

2008
Cyclophosphamide treatment improves microvessel damage in systemic sclerosis.
    Clinical rheumatology, 2009, Volume: 28, Issue:4

    Topics: Aged; Azathioprine; Cyclophosphamide; Female; Humans; Immune System; Immunosuppressive Agents; Infla

2009
Azathioprine for ocular inflammatory diseases.
    American journal of ophthalmology, 2009, Volume: 148, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Child; Female; Follow-Up Studies; Humans;

2009
Mycophenolate mofetil reduces alveolar inflammation, acute rejection and graft loss due to bronchiolitis obliterans syndrome after lung transplantation.
    Pulmonary pharmacology & therapeutics, 2010, Volume: 23, Issue:5

    Topics: Adult; Azathioprine; Bronchiolitis Obliterans; Bronchoalveolar Lavage Fluid; Female; Graft Rejection

2010
Spontaneous pregnancy in a patient with a relapse of lymphocytic hypophysitis successfully treated with azathioprine and glucocorticoids.
    Endocrine, 2011, Volume: 39, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Female; Humans; Inflammation; Pituitary Diseases; Pre

2011
Response to immunotherapy in CLIPPERS syndrome.
    Journal of neurology, 2011, Volume: 258, Issue:11

    Topics: Adult; Azathioprine; Brain; Brain Diseases; Female; Glucocorticoids; Humans; Immunoglobulins, Intrav

2011
Extra-pancreatic manifestations of IgG4-related systemic disease: a single-centre experience of treatment with combined immunosuppression.
    Internal medicine journal, 2013, Volume: 43, Issue:4

    Topics: Aged; Autoimmune Diseases; Azathioprine; Biomarkers; Drug Therapy, Combination; Female; Follow-Up St

2013
Diayangambin exerts immunosuppressive and anti-inflammatory effects in vitro and in vivo.
    Planta medica, 2002, Volume: 68, Issue:12

    Topics: Animals; Anisoles; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Dexamethasone; Dinoproston

2002
Preventing toxicity with a gene test.
    Science (New York, N.Y.), 2003, Oct-24, Volume: 302, Issue:5645

    Topics: Advisory Committees; Azathioprine; Child; Drug Labeling; Drug Utilization; Genetic Testing; Humans;

2003
Lymphocytic hypophysitis successfully treated with azathioprine: first case report.
    Journal of neurology, neurosurgery, and psychiatry, 2003, Volume: 74, Issue:11

    Topics: Adrenal Cortex Hormones; Azathioprine; Drug Resistance; Humans; Immunosuppressive Agents; Inflammati

2003
Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine.
    Journal of pediatric gastroenterology and nutrition, 2004, Volume: 38, Issue:5

    Topics: Adolescent; Azathioprine; Biomarkers; Blood Sedimentation; C-Reactive Protein; Child; Female; Humans

2004
Selective inhibition of inflammatory gene expression in activated T lymphocytes: a mechanism of immune suppression by thiopurines.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 312, Issue:2

    Topics: Annexin A5; Apoptosis Regulatory Proteins; Azathioprine; Cells, Cultured; Coloring Agents; Dose-Resp

2005
[Wegener granulomatosis: a pulmonary pediatric form].
    Annales de pathologie, 2005, Volume: 25, Issue:3

    Topics: Abscess; Adrenal Cortex Hormones; Azathioprine; Child; Cyclophosphamide; Female; Granulomatosis with

2005
A method for extracting muscle information from serum creatine kinase measurements--its potential value in the monitoring and management of inflammatory muscle disease.
    Medical hypotheses, 2006, Volume: 66, Issue:3

    Topics: Animals; Azathioprine; Clinical Enzyme Tests; Creatine Kinase; Drug Interactions; Humans; Indoles; I

2006
Severe gastrointestinal inflammation in adult dermatomyositis: characterization of a novel clinical association.
    The American journal of the medical sciences, 2006, Volume: 332, Issue:6

    Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Dermatomyositis; Fatal Outcome; Fem

2006
Demographic, pharmacologic, and periodontal variables for gingival overgrowth in subjects medicated with cyclosporin in the absence of calcium channel blockers.
    Journal of periodontology, 2007, Volume: 78, Issue:2

    Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Calcium Channel Blockers; Chi-Square Distribution; Cy

2007
Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients.
    Inflammatory bowel diseases, 2007, Volume: 13, Issue:9

    Topics: Adult; Algorithms; Azathioprine; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Female

2007
Combined effects of temperature and immunosuppressive drug therapy on allograft rejection in goldfish.
    Transplantation, 1967, Sep-05, Volume: 5, Issue:5

    Topics: Animals; Azathioprine; Cyprinidae; Drug Synergism; Inflammation; Methotrexate; Temperature; Transpla

1967
Experimental prevention of nerve homograft rejection by use of immunosuppressive drugs.
    Journal of neurosurgery, 1967, Volume: 27, Issue:5

    Topics: Animals; Azathioprine; Inflammation; Nerve Regeneration; Peripheral Nerves; Radiation Effects; Rats;

1967
[Characteristics of mononuclear phagocytes in their normal state and in inflammation].
    Folia haematologica (Leipzig, Germany : 1928), 1984, Volume: 111, Issue:2

    Topics: Azathioprine; Bone Marrow Transplantation; Chimera; Esterases; Glucocorticoids; Humans; Inflammation

1984
Azathioprine-associated pulmonary dysfunction.
    Chest, 1983, Volume: 83, Issue:4

    Topics: Adult; Allopurinol; Azathioprine; Crohn Disease; Humans; Inflammation; Kidney Calculi; Lung Diseases

1983
Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy.
    The American journal of cardiology, 1980, Volume: 45, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Azathioprine; Biopsy; Humans; Inflammation; Male; Methylprednisolo

1980
Successful treatment of a patient with retractile mesenteritis with prednisone and azathioprine.
    Gastroenterology, 1980, Volume: 79, Issue:2

    Topics: Azathioprine; Drug Therapy, Combination; Female; Humans; Inflammation; Mesentery; Middle Aged; Predn

1980
CsA levels in the early posttransplant period--predictive of chronic rejection in liver transplantation?
    Transplantation, 1995, Apr-27, Volume: 59, Issue:8

    Topics: Adult; Age Factors; Azathioprine; Child; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; F

1995
Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy.
    Ophthalmology, 1993, Volume: 100, Issue:12

    Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Eye Diseases; Female; Humans

1993
Abnormal T-cell costimulation by proteins of the extracellular matrix in human renal allografting.
    Research in immunology, 1993, Volume: 144, Issue:5

    Topics: Arteritis; Azathioprine; Collagen; Cyclosporine; Endothelium, Vascular; Extracellular Matrix Protein

1993
Factors associated with fetal losses in severe systemic lupus erythematosus.
    Lupus, 1996, Volume: 5, Issue:2

    Topics: Adult; Analysis of Variance; Azathioprine; Case-Control Studies; Chloroquine; Cohort Studies; Congen

1996
An experimental model of chronic kidney allograft rejection under triple-drug treatment in the rat.
    Transplantation proceedings, 1997, Volume: 29, Issue:7

    Topics: Animals; Azathioprine; Biopsy, Needle; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Gra

1997
Effect of immunosuppression on obliterative lesions in a heterotopic large-animal bronchial allograft model.
    Transplantation proceedings, 1997, Volume: 29, Issue:7

    Topics: Animals; Azathioprine; Bronchi; Bronchiolitis Obliterans; Cartilage; Cyclosporine; Drug Therapy, Com

1997
[FDG PET for the localization diagnosis in inflammatory disease of unknown origin--two case reports].
    Nuklearmedizin. Nuclear medicine, 2001, Volume: 40, Issue:4

    Topics: Anti-Inflammatory Agents; Azathioprine; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Imm

2001
Cell kinetics during inflammation.
    Agents and actions. Supplements, 1977, Issue:3

    Topics: Acute Disease; Animals; Azathioprine; Cell Movement; Chronic Disease; Exudates and Transudates; Gluc

1977
Assessment of anti-inflammatory drugs in the rat using subcutaneous implants of polyurethane foam impregnated with dead tubercle bacilli.
    Annals of the rheumatic diseases, 1975, Volume: 34, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Aspirin; Azathioprine; Biological Assay; Cyclophosphamide; Female

1975
The effect of hydrocortisone acetate and azathioprine (Imuran) on the kinetics of neutrophilic polymorphonuclear leucocytes during an acute inflammation.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1977, Volume: 154, Issue:1

    Topics: Animals; Ascitic Fluid; Azathioprine; Bone Marrow; Bone Marrow Cells; Cell Movement; Hydrocortisone;

1977
The effect of azathioprine (Imuran) on the cell cycle of promonocytes and the production of monocytes in the bone marrow.
    The Journal of experimental medicine, 1975, Mar-01, Volume: 141, Issue:3

    Topics: Acute Disease; Animals; Azathioprine; Bone Marrow; Bone Marrow Cells; Cell Count; Cell Division; Cel

1975
The effect of azathioprine (Imuran) on the kinetics of monocytes and macrophages during the normal steady state and an acute inflammatory reaction.
    Blood, 1975, Volume: 46, Issue:1

    Topics: Animals; Autoradiography; Azathioprine; Cells, Cultured; Germ-Free Life; Inflammation; Kinetics; Leu

1975
Inflammatory mediators in allograft malfunction: a new concept in the cyclosporin era.
    Transplantation proceedings, 1989, Volume: 21, Issue:1 Pt 1

    Topics: Azathioprine; Complement System Proteins; Cyclosporins; Edema; Fluorescent Antibody Technique; Graft

1989
Differential effects of azathioprine (Aza), cyclosporine A (CsA) and dexamethasone (Dexa) on lymphokine mediated inflammation (LMI) in rejecting allografts.
    Transplantation proceedings, 1989, Volume: 21, Issue:1 Pt 1

    Topics: Animals; Azathioprine; Cells, Cultured; Cyclosporins; Dexamethasone; Female; Graft Rejection; Immuno

1989
Distinct phenotypic composition of diffuse interstitial and perivascular focal infiltrates in renal allografts: a morphometric analysis of cellular infiltration under conventional immunosuppressive therapy and under cyclosporine A.
    Clinical nephrology, 1988, Volume: 30, Issue:2

    Topics: Administration, Oral; Antibodies, Monoclonal; Azathioprine; B-Lymphocytes; Cell Aggregation; Cyclosp

1988
Posterior scleritis: a clinical and histological survey.
    Eye (London, England), 1988, Volume: 2 ( Pt 3)

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; C

1988
Effect of predosing animals with immunosuppressive drugs on immune and non-immune induced inflammatory responses.
    Archives internationales de pharmacodynamie et de therapie, 1974, Volume: 211, Issue:1

    Topics: Adjuvants, Immunologic; Animals; Arthritis; Azathioprine; Carrageenan; Cyclophosphamide; Dexamethaso

1974
[Experimental findings on the site of action and on pharmacodynamics of cytostatic and antiphlogistic drugs in inflammation].
    Verhandlungen der Deutschen Gesellschaft fur Rheumatologie, 1972, Volume: 2

    Topics: Animals; Azathioprine; Cyclophosphamide; Glycosaminoglycans; Granulation Tissue; Hematopoietic Syste

1972
[Animal experiments on the anti-inflammatory and immunosuppressive effect of cytostatic agents].
    Arzneimittel-Forschung, 1973, Volume: 23, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Azathioprine; Cyclic P-Oxides; Cyclophosphamide; Dose-Response Re

1973
Systemic (allergic?) vasculitis.
    The Journal of allergy and clinical immunology, 1974, Volume: 54, Issue:1

    Topics: Antigen-Antibody Complex; Azathioprine; Complement System Proteins; Creatinine; Diphenhydramine; Ery

1974
Scleritis and rheumatoid arthritis.
    Annals of the rheumatic diseases, 1971, Volume: 30, Issue:4

    Topics: Adrenocorticotropic Hormone; Age Factors; Arteritis; Arthritis, Rheumatoid; Azathioprine; Betamethas

1971
Impaired drug metabolism in rats associated with acute inflammation: a possible assay for anti-injury agents.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1974, Volume: 145, Issue:1

    Topics: Aminopyrine; Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Azathioprine; Biological Assa

1974
The effect of various immunosuppressive agents on the vascular and cellular response to carvageenan in the rat.
    The Journal of pathology, 1973, Volume: 109, Issue:2

    Topics: Animals; Azathioprine; Busulfan; Carrageenan; Chlorambucil; Cyclophosphamide; Edema; Immunosuppressi

1973
Digital artery thrombosis and vasculitis in juvenile rheumatoid arthritis.
    Canadian Medical Association journal, 1973, Sep-01, Volume: 109, Issue:5

    Topics: Arteries; Arteritis; Arthritis, Juvenile; Azathioprine; Blood Vessels; Child, Preschool; Female; Gan

1973
Progressive occlusive endarteritis. A case report.
    Acta pathologica et microbiologica Scandinavica. Section A, Pathology, 1973, Volume: 81, Issue:6

    Topics: Adult; Arterial Occlusive Diseases; Arteries; Autopsy; Azathioprine; Coronary Vessels; Endarteritis;

1973
Hepatic sepsis after liver transplantation in dogs and pigs.
    Archives of pathology, 1969, Volume: 88, Issue:2

    Topics: Animals; Antilymphocyte Serum; Azathioprine; Cholangitis; Dogs; Immunosuppressive Agents; Infections

1969
Histologic changes associated with rejection of canine lung transplants.
    The Journal of thoracic and cardiovascular surgery, 1971, Volume: 62, Issue:2

    Topics: Animals; Azathioprine; Biopsy; Dogs; Edema; Graft Rejection; Hemorrhage; Immunosuppression Therapy;

1971
The influence of anti-inflammatory and immunosuppressant drugs on Nystatin induced oedema.
    Pharmacology, 1971, Volume: 5, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Arthritis; Aspirin; Azathioprine; Ch

1971
A comparison of immunosuppressive and anti-inflammatory agents in the rat.
    Clinical and experimental immunology, 1971, Volume: 9, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Antibody Formation; Antilymphocyte Serum; Arthritis; Azathioprine

1971
[Acid alpha 1 -glycoprotein as indicator of inflammation activity].
    Arzneimittel-Forschung, 1971, Volume: 21, Issue:11

    Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Female; Glycoproteins;

1971
[Ophthalmological symptomatology, therapy and prognosis of Fuch's and Lyell's syndromes].
    Klinische Monatsblatter fur Augenheilkunde, 1970, Volume: 157, Issue:3

    Topics: Adult; Azathioprine; Body Weight; Corneal Opacity; Cortisone; Diagnosis, Differential; Entropion; Er

1970